Developing Robust Subgroup Analysis Methods for Randomized Controlled Trials
Award amount
$265,170Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MARTINGALE RESEARCH CORPORATION
- Proposal award date
- 2019-07-01
- Contract end date
- 2020-06-30
- UEI
- T9NGMH8MYAR3
- Solicitation number
- PA18-574
- Topic code
- NIDA
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Developing Robust Risk Models for the Persistent Inflammation Immunosuppression and Catabolism Syndrome
- Developing Robust Chronic Critical Illness Risk Models
- Robust Suicide/Reinjury Risk Models to Assess Healthcare Systems
- Dramatic Improvements to the Doubly Labeled Water Technique by Measurement of 17O
- Robust Classification Methods for Categorical Regression
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
32 SBIR/STTR records share this UEI (1987–2019). Reported award amounts total $10,833,491. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, National Aeronautics and Space Administration